These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2360797

  • 1. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
    Macdonald DR, Gaspar LE, Cairncross JG.
    Ann Neurol; 1990 May; 27(5):573-4. PubMed ID: 2360797
    [Abstract] [Full Text] [Related]

  • 2. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C, Shonka N, Smith L, Liu D, De Groot J.
    Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
    [Abstract] [Full Text] [Related]

  • 3. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
    Zander T, Nettekoven W, Kraus JA, Pels H, Ko YD, Vetter H, Klockgether T, Schlegel U.
    J Neurol; 2002 Aug; 249(8):1055-7. PubMed ID: 12195453
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
    Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C.
    J Clin Oncol; 1994 Oct; 12(10):2013-21. PubMed ID: 7931469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
    Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ.
    Cancer; 2005 Feb 15; 103(4):802-9. PubMed ID: 15637687
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
    Intergroup Radiation Therapy Oncology Group Trial 9402University of Calgary, Calgary, Alberta, Canada; e-mail: jgcairnx@ucalgary.ca, Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, Mehta M, Curran W.
    J Clin Oncol; 2006 Jun 20; 24(18):2707-14. PubMed ID: 16782910
    [Abstract] [Full Text] [Related]

  • 9. Anaplastic oligodendroglial tumors: a tale of two trials.
    Gilbert MR, Lang FF.
    J Clin Oncol; 2006 Jun 20; 24(18):2689-90. PubMed ID: 16782906
    [No Abstract] [Full Text] [Related]

  • 10. T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
    Esparragosa Vazquez I, Ndiaye M, Di Stefano AL, Younan N, Larrieu-Ciron D, Seyve A, Picart T, Meyronet D, Boutet C, Vassal F, Carpentier C, Figarella-Branger D, Dehais C, Forest F, Rivoirard R, Ducray F, POLA network.
    Eur J Neurol; 2023 Sep 20; 30(9):2879-2883. PubMed ID: 37204066
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.
    Streffer J, Schabet M, Bamberg M, Grote EH, Meyermann R, Voigt K, Dichgans J, Weller M.
    J Neurol; 2000 Apr 20; 247(4):297-302. PubMed ID: 10836623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
    Yamamoto M, Iwaasa M, Nonaka M, Tsugu H, Nabeshima K, Fukushima T.
    Anticancer Res; 2005 Apr 20; 25(6A):3715-23. PubMed ID: 16302731
    [Abstract] [Full Text] [Related]

  • 15. Radiotherapy plus temozolomide or PCV in patients with anaplastic oligodendroglioma 1p19q codeleted.
    Gonzalez-Aguilar A, Reyes-Moreno I, Peiro-Osuna RP, Hernandez-Hernandez A, Gutierrez-Aceves A, Santos-Zambrano J, Guerrero-Juarez V, Lopez-Martinez M, Castro-Martinez E.
    Rev Neurol; 2018 Oct 16; 67(8):293-297. PubMed ID: 30289152
    [Abstract] [Full Text] [Related]

  • 16. PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.
    Diabira S, Rousselet MC, Gamelin E, Soulier P, Jadaud E, Menei P.
    J Neurooncol; 2001 Oct 16; 55(1):45-50. PubMed ID: 11804282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.
    Tang BN, Sadeghi N, Branle F, De Witte O, Wikler D, Goldman S.
    J Neurooncol; 2005 Jan 16; 71(2):161-8. PubMed ID: 15690133
    [Abstract] [Full Text] [Related]

  • 19. Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy.
    Lebrun C, Fontaine D, Bourg V, Ramaioli A, Chanalet S, Vandenbos F, Lonjon M, Fauchon F, Paquis P, Frenay M.
    Eur J Neurol; 2007 Apr 16; 14(4):391-8. PubMed ID: 17388986
    [Abstract] [Full Text] [Related]

  • 20. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
    Bouffet E, Mornex F, Jouvet A, Thiesse P, Mertens P, Helfre S, Sindou M, Bret P.
    Bull Cancer; 1997 Oct 16; 84(10):951-6. PubMed ID: 9435796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.